Monoclonal Antibody Therapies for High Risk Neuroblastoma

por Furman, Wayne L
Publicado 2021

Pharmacokinetically guided dosing of oral sorafenib in pediatric hepatocellular carcinoma: A simulation study

por Panetta, John C., Campagne, Olivia, Gartrell, Jessica, Furman, Wayne, Stewart, Clinton F.
Publicado 2021

Bilateral Diffuse Nodular Pulmonary Ossification Mimicking Metastatic Disease in a Patient with Fibrolamellar Hepatocellular Carcinoma

por Sutthatarn, Pattamon, Morin, Cara E., Gartrell, Jessica, Furman, Wayne L., Langham, Max R., Santiago, Teresa, Murphy, Andrew J.
Publicado 2021

A Phase 1 and pharmacokinetic study evaluating daily or weekly schedules of the humanized anti-GD2 antibody hu14.18K322A in recurrent/refractory solid tumors

por Bishop, Michael W., Hutson, Paul R., Hank, Jacquelyn A., Sondel, Paul M., Furman, Wayne L., Meagher, Michael M., Navid, Fariba, Santana, Victor M.
Publicado 2020

Risk factors associated with metastatic site failure in patients with high-risk neuroblastoma

por Lucas, John Thomas, Wakefield, Daniel Victor, Doubrovin, Michael, Li, Yimei, Santiago, Teresa, Federico, Sara Michele, Merchant, Thomas E., Davidoff, Andrew M., Krasin, Matthew J., Shulkin, Barry L., Santana, Victor M., Lee Furman, Wayne
Publicado 2022

Longitudinal NK cell kinetics and cytotoxicity in children with neuroblastoma enrolled in a clinical phase II trial

por Nguyen, Rosa, Sahr, Natasha, Sykes, April, McCarville, Mary Beth, Federico, Sara M, Sooter, Amanda, Cullins, David, Rooney, Barbara, Janssen, William E, Talleur, Aimee C, Triplett, Brandon M, Anthony, Gwendolyn, Dyer, Michael A, Pappo, Alberto S, Leung, Wing H, Furman, Wayne L
Publicado 2020